[痴呆症研究的进展:对血细胞和血成分的新见解]
Shuntatsu Nakazawa1, Rinku Ogawa1, Takuya Sasaki1
1Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University.
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
|August 31, 2025
概括
日本
科学领域:
- 老年学
- 神经学
- 公共卫生
背景情况:
- 日本面临着人口老龄化和老年痴呆症诊断的日益增加的挑战.
- 由于脑损伤导致的痴呆症会逐渐影响认知功能,日常活动和社交.
- 目前神经退行性痴呆症的治疗方法不足.
研究的目的:
- 解决日本老年人口中痴呆症发病率上升的问题.
- 探索痴呆症对日常生活和社会参与的影响.
- 突出现有的神经退行性疾病医疗干预措施的局限性.
主要方法:
- 对日本人口老龄化数据的审查.
- 对痴呆症患者认知衰退模式的分析.
- 评估目前痴呆症治疗的疗效.
主要成果:
- 日本人口老龄化与痴呆病例的增加直接相关.
- 认知障碍显著影响日常生活活动 (ADL) 和社会互动.
- 现有的医疗干预措施无法完全治愈神经退行性痴呆症.
结论:
- 日本的老年痴呆症患病率越来越高,
- 进一步的研究对于开发更有效的痴呆症治疗至关重要.
- 解决痴呆症的社会和经济影响是重点公共卫生问题.
相关概念视频
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666


